[Form 4] Intapp, Inc. Insider Trading Activity
John T. Hall, Chief Executive Officer and Director of Intapp, Inc. (INTA), exercised options and sold shares under a pre-existing 10b5-1 plan on 08/18/2025. He exercised an employee stock option with a $7.45 exercise price to acquire 80,000 shares and simultaneously sold 80,000 shares in multiple transactions at weighted-average prices of $41.8689, $42.5607 and $43.0964. Following these transactions, reported beneficial ownership declined from 5,678,775 to 5,598,775 shares. The filing notes the option shares were fully vested and that the 10b5-1 plan was established on September 13, 2024. The Form 4 was signed by an attorney-in-fact on 08/19/2025.
- Transactions executed under a 10b5-1 plan, indicating prearranged trading instructions
- Option exercise at a $7.45 strike, explicitly stated and fully vested
- Detailed weighted-average sale prices and price ranges provided, with an offered breakdown on request
- Reported beneficial ownership decreased from 5,678,775 to 5,598,775 shares following the trades
- Material number of shares (80,000) sold by the CEO, which reduces insider shareholdings
Insights
TL;DR: CEO exercised low-strike options and sold the acquired shares under a pre-set 10b5-1 plan; ownership decreased modestly.
The filing shows an exercise of an employee option with a $7.45 strike for 80,000 shares and concurrent sales of those 80,000 shares at weighted-average prices around $41.87–$43.10 on 08/18/2025. These transactions were executed pursuant to a 10b5-1 plan established on September 13, 2024, and the shares underlying the option were fully vested. Reported beneficial ownership moved from 5,678,775 to 5,598,775 shares across the reported trades. For investors, this is a routine liquidity event by an insider using a Rule 10b5-1 plan, without additional disclosed company-level developments.
TL;DR: Insider transactions follow an established trading plan, with proper disclosure and attorney-in-fact signature.
The disclosure confirms the trades were made pursuant to a 10b5-1 plan and provides weighted-average sale prices and price ranges for the multiple sales. The Form 4 includes the required statement that the option shares were fully vested and the signature executed by an attorney-in-fact on 08/19/2025. The filing contains the explanatory footnote offering to provide detailed per-price sale breakdowns upon request, which aligns with transparent disclosure practices for insider transactions.